Mei Wu

机构：Fujian Normal University, Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Second Hospital of Shandong University, Freie Universität Berlin, Capital Normal University · ORCID：0000-0002-2467-1402

发表论文 107 篇 · 总被引 1169 次 · h-index 14

代表论文

• Organic-inorganic hybrid materials for catalytic transfer hydrogenation of biomass-derived carbonyl-containing compounds (2024 · Coordination Chemistry Reviews · 被引 55)
• Catalyst-Free Acetalization of Biobased Furfural into Cyclic Acetal Fuel Additives with Biogenic Ethylene Glycol (2023 · ACS Sustainable Chemistry & Engineering · 被引 18)
• Molecular docking and molecular dynamics study Lianhua Qingwen granules (LHQW) treats COVID-19 by inhibiting inflammatory response and regulating cell survival (2022 · Frontiers in Cellular and Infection Microbiology · 被引 16)
• Nuclear import carrier Hikeshi cooperates with HSP70 to promote murine oligodendrocyte differentiation and CNS myelination (2023 · Developmental Cell · 被引 15)
• Nucleoporin Seh1 maintains Schwann cell homeostasis by regulating genome stability and necroptosis (2023 · Cell Reports · 被引 14)
• Enhanced removal of typical antibiotics and the changes of bacterial communities in an electro-assisted vertical flow constructed wetland (2024 · Environmental Technology & Innovation · 被引 13)